What new channels did YouTube TV add in July 2026? We explore the expanded Allen Media Group partnership bringing HBCU Go, ...
Despite multiple complaints — and videos — of physical abuse and mistreatment of students, Arkansas' Delta Institute continues to receive public funds. It is just one of hundreds of private schools ...
Some school districts are ahead of the curve. During a June 30 panel discussion at the ISTELive 26 + ASCD Annual Conference ...
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1222 ET – The failure of Wainua, a heart disease drug developed ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Things are happening fast at BridgeBio as it plugs away at the launch of blockbuster-in-waiting Attruby and prepares to potentially introduce three new drugs to the market within the next 12 months.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. BridgeBio’s lead drug Attruby (acoramidis) is tracking a ...
Education Secretary Linda McMahon will testify Thursday morning before the House Education and Workforce Committee about the Trump administration’s priorities for the department. Trump has argued that ...
BridgeBio reported $195 million in total first-quarter revenue. Heart drug Attruby accounted for nearly $181 million in sales, representing 24% growth from the fourth quarter and 392% year-over-year ...
BridgeBio remains a compelling Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics following Pfizer’s patent settlements. Attruby’s peak annual sales are conservatively ...